Olprinone
Olprinone is a type of cardiotonic agent that is primarily used in the treatment of congestive heart failure and other cardiovascular diseases. It is classified as a phosphodiesterase 3 inhibitor, which means it works by inhibiting the action of the enzyme phosphodiesterase 3. This results in an increase in the concentration of cyclic AMP in heart muscle cells, leading to an increase in the force of contraction of the heart.
Mechanism of Action[edit | edit source]
The primary mechanism of action of Olprinone is the inhibition of phosphodiesterase 3. This enzyme is responsible for breaking down cyclic AMP in the cells of the heart muscle. By inhibiting this enzyme, Olprinone increases the concentration of cyclic AMP, which in turn increases the force of contraction of the heart. This helps to improve the pumping efficiency of the heart in patients with congestive heart failure.
Clinical Use[edit | edit source]
Olprinone is used in the treatment of congestive heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. It may also be used in the treatment of other cardiovascular diseases, such as angina pectoris, myocardial infarction, and cardiomyopathy.
Side Effects[edit | edit source]
Like all medications, Olprinone can cause side effects. The most common side effects include nausea, vomiting, and diarrhea. Less common side effects can include hypotension (low blood pressure), tachycardia (fast heart rate), and arrhythmia (irregular heart rhythm).
Contraindications[edit | edit source]
Olprinone should not be used in patients with known hypersensitivity to the drug. It is also contraindicated in patients with severe renal impairment, as the drug is primarily excreted by the kidneys.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
 | This cardiovascular system article is a stub. You can help WikiMD by expanding it. |
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
